Aristacare At Manchester

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0550 during a standard health inspection conducted on 2025-08-27.

Category: Resident Rights Deficiencies

The facility was found deficient in the following area: Honor the resident's right to a dignified existence, self-determination, communication, and to exercise his or her rights.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0582 during a standard health inspection conducted on 2025-08-27.

Category: Resident Rights Deficiencies

The facility was found deficient in the following area: Give residents notice of Medicaid/Medicare coverage and potential liability for services not covered.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0693 during a standard health inspection conducted on 2025-08-27.

Category: Quality of Life and Care Deficiencies

The facility was found deficient in the following area: Ensure that feeding tubes are not used unless there is a medical reason and the resident agrees; and provide appropriate care for a resident with a feeding tube.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0761 during a standard health inspection conducted on 2025-08-27.

Category: Pharmacy Service Deficiencies

The facility was found deficient in the following area: Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0842 during a complaint investigation conducted on 2025-08-27.

Category: Resident Assessment and Care Planning Deficiencies

The facility was found deficient in the following area: Safeguard resident-identifiable information and/or maintain medical records on each resident that are in accordance with accepted professional standards.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0880 during a standard health inspection conducted on 2025-08-27.

Category: Infection Control Deficiencies

The facility was found deficient in the following area: Provide and implement an infection prevention and control program.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.

Federal health inspectors cited ARISTACARE AT MANCHESTER in MANCHESTER, NJ for a deficiency under regulatory tag F-F0882 during a standard health inspection conducted on 2025-08-27.

Category: Infection Control Deficiencies

The facility was found deficient in the following area: Designate a qualified infection preventionist to be responsible for the infection prevent and control program in the nursing home.

Scope/Severity Level D: isolated, no actual harm with potential for more than minimal harm.

While no actual harm was documented, there was potential for more than minimal harm to residents.

This was one of 7 deficiencies cited during this inspection of ARISTACARE AT MANCHESTER.

Correction Status: Deficient, Provider has date of correction.

The facility reported correction as of 2025-10-21.